ARCHIVES

More Cost-Effective To Use Cetuximab In Patients With Wild-Type KRAS Gene

This article is from The Cancer Letter archive.

Vol. 32 No. 8 | August 28, 2009

Download PDF Visit The Full Archive

Related Articles

New Community Control Program May Be Developed

October 24, 1975

DCBD Board Okays Concept Of Program Announcement To Stimulate Human Monoclonal Antibody Research

June 4, 1982

NCI Cooperative Group Clinical Trials Approved

July 31, 2009

Anthrax Found At Local P.O.

November 2, 2001

Obituary: Daniel Nathans, 71, Won Nobel For Use of Restriction Enzyme

November 19, 1999

Under Ultimatum, NIH Databases Remove “Misconduct” Tags From Papers By Fisher

February 24, 1995